ARCHIVES

Avastin doubles progression-free survival in metastatic disease.

This article is from The Cancer Letter archive.

Vol. 31 No. 21 | May 27, 2005

Download PDF Visit The Full Archive

Related Articles

NRC considering “Escalated” Enforcement Action Against NIH

February 2, 1996

In Brief: Contracts For Comparative NMR Imaging studies Awarded To Five Institutions; NCI Staff Honored

June 8, 1984

FCRC Decision Due In 90 Days, Upton Says

November 24, 1978

Oncology Faces Cuts In CMS Revamp Of Physician Payments Under Part B.

July 10, 2009

House Authorizes $30M For Pediatric Cancer Research.

June 13, 2008

ACS To Accept Database On Method Of Unconventional Rx

November 26, 1993